Skip to main content
FRMSL logo

FRMSL — Investor Relations & Filings

Ticker · 4746 ISIN · TW0004746003 TW Manufacturing
Open in API
Filings indexed 1,872 across all filing types
Latest filing 2023-05-04 Director's Dealing
Country TW Taiwan
Listing TW 4746

About FRMSL

www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
112年04月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It provides data on stock ownership, changes in holdings, and trust shares. This type of information corresponds to disclosures about personal share transactions or holdings by company directors and executives. There is no indication of financial results, earnings, management discussion, or other report types. The document is not an announcement of a report but a detailed disclosure of insider shareholdings. Therefore, the document fits the category of Director's Dealing (DIRS).
2023-05-04 Chinese
澄清112年5月3日財訊快報之相關報導
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (台耀化學股份有限公司) clarifying a media report about its financial performance estimates. It states that the financial figures should be based on official disclosures and not media speculation. The document is only 656 characters long and does not contain any actual financial statements or detailed financial data. It is essentially a regulatory clarification or statement rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-03 Chinese
112年3月背書保證與資金貸與
Capital/Financing Update Classification · 95% confidence The document is a financial disclosure from a listed company (台耀) providing information about fund loans and endorsement guarantees for the current and previous months, including limits and balances. The content is concise, numerical, and relates to capital or financing status rather than a full financial report or announcement of a meeting or vote. The document length is short (610 characters), and it does not indicate it is an announcement of a report publication or a certification. The data pertains to financing activities (fund loans and guarantees), which aligns with Capital/Financing Update filings. Therefore, the document is best classified as a Capital/Financing Update (CAP).
2023-04-10 Chinese
112年3月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 台耀, with data for March 2023 (民國112年03月). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document is short (768 characters) and primarily presents financial summary data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release or investor presentation. It is a regulatory disclosure of financial data, likely a routine financial summary filing. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2023-04-10 Chinese
112年03月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, general managers, and their related parties. It provides data on stock ownership, changes in holdings, and trust shares. There is no indication of financial statements, earnings data, management discussion, or meeting materials. The content is focused on insider shareholdings and transactions. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives. The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2023-04-07 Chinese
112年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by insiders and related parties of the company 台耀化學股份有限公司. It lists shareholdings by directors, independent directors, general managers, deputy general managers, and other key personnel. The document does not contain financial statements, earnings data, or management discussion. It is a disclosure of insider shareholdings and pledges, which corresponds to reporting of personal share transactions or holdings by company directors and executives. There is no indication of it being a full annual report, audit report, earnings release, or other financial report. The document length is 4109 characters, which is relatively short but contains detailed insider shareholding data. Therefore, the best fitting category is Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives.
2023-04-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.